Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALEXIUM INTERNATIONAL GROUP LIMITED Call Transcript 2020

Feb 26, 2020

64351_rns_2020-02-26_15d39496-db6f-41cd-a791-9d5658557c65.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [612 x 113] intentionally omitted <==

ASX MEDIA RELEASE |27 February 2020

Alexium to Host Investor Conference Call

Perth (Australia), Greer (South Carolina, US) – 27 February 2020: Alexium International Group Limited (ASX: AJX) today announced that the Company will host a conference call and live audio webcast at 9:00am AEST on Friday, 28 February 2020. CEO Bob Brookins and CFO Jason Lewis will review Alexium’s progress over this period as well as provide updates on major initiatives.


To join the online meeting


  1. Go to https://communique.webex.com/communique/j.php?MTID=m21eb882457bbb7f240659c6acbeb9ce6

  2. Enter your name and email address.

  3. Enter the meeting password: (This meeting does not require a password.)

  4. Click "Join".

  5. Once you have joined, attendees can post questions for management.


To join the teleconference only


US Toll-Free: 1-877-279-8071 International: +1-602-563-8463 Conference ID: 7983999

ENDS

About Alexium International Group Limited

Alexium International Group Limited (ASX: AJX) holds proprietary patent applications for novel technologies developed to provide flame retardancy for a wide range of materials. These environmentally friendly flame retardants have applications for several industries and can be customized. Further, Alexium develops proprietary products for advanced thermoregulation utilizing phase change materials. Applications under development include but are not limited to textiles, packaging, electronics, and building materials. Alexium’s chemical treatments are currently marketed as Alexicool® and Alexiflam®. For additional information about Alexium, please visit www.alexiuminternational.com.

Authorisation

Authorised for issue to ASX by Dr Robert Brookins, Chief Executive Officer & Managing Director.

For more information:

Jason Lewis [email protected] P: +1 864 254 9923

==> picture [545 x 18] intentionally omitted <==

==> picture [612 x 113] intentionally omitted <==

Alexium’s US corporate office details:

A: 350 W. Phillips Rd, Greer, SC 29650 USA

P: +1-864 254 9923

Alexium’s registered office details: A: Level 11, 124 St Georges Terrace, Perth WA, 6000, Australia P: +61 8 9278 2538

==> picture [545 x 18] intentionally omitted <==